356 reports of this reaction
1.2% of all LIFITEGRAST reports
#18 most reported adverse reaction
PRODUCT USE COMPLAINT is the #18 most commonly reported adverse reaction for LIFITEGRAST, manufactured by Bausch & Lomb Incorporated. There are 356 FDA adverse event reports linking LIFITEGRAST to PRODUCT USE COMPLAINT. This represents approximately 1.2% of all 29,776 adverse event reports for this drug.
Patients taking LIFITEGRAST who experience product use complaint should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PRODUCT USE COMPLAINT is a less commonly reported adverse event for LIFITEGRAST, but still significant enough to appear in the safety profile.
In addition to product use complaint, the following adverse reactions have been reported for LIFITEGRAST:
The following drugs have also been linked to product use complaint in FDA adverse event reports:
PRODUCT USE COMPLAINT has been reported as an adverse event in 356 FDA reports for LIFITEGRAST. This does not prove causation, but indicates an association observed in post-market surveillance data.
PRODUCT USE COMPLAINT accounts for approximately 1.2% of all adverse event reports for LIFITEGRAST, making it a notable side effect.
If you experience product use complaint while taking LIFITEGRAST, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.